Viceroy Research

Company	Stock Exchange	Ticker	# of Reports	Most Recent Update	Our Research
Abalance	TYO	3856	4	May 22, 2023	View Reports
Adler Group	ETR	ADJ	4	May 3, 2022	View Reports
AMD	NASDAQ	AMD	2	March 22, 2018	View Reports
Arbor Realty	NYSE	ABR	20	September 3, 2024	View Reports
Athenex	NASDAQ	ATNX	10	November 20, 2019	View Reports
Caesarstone	NASDAQ	CSTE	2	August 1, 2017	View Reports
Capitec	JSE	CPI	6	May 21, 2018	View Reports
Ebix	NASDAQ	EBIX	7	July 1, 2019	View Reports
Globe Life	NYSE	GL	13	August 6, 2024	View Reports
Grenke	XTRA	GLJ	9	October 22, 2020	View Reports
Home REIT	LSE	HOME	2	November 30, 2022	View Reports
Medical Properties Trust	NASDAQ	MPW	18	September 9, 2024	View Reports
MiMedx	NASDAQ	MDXG	28	September 20, 2020	View Reports
NEPI Rockcastle	JSE	NEPI	3	December 6, 2018	View Reports
Neuroderm	NASDAQ	NDRM	3	September 6, 2017	View Reports
Pareteum	NASDAQ	TEUM	5	July 17, 2019	View Reports
Pretium	TSE/NYSE	PVG	4	January 10, 2019	View Reports
ProSieben	ETR	PSM	1	March 6, 2018	View Reports
Quintis	ASXL	QIN	1	May 14, 2017	View Reports
ReconAfrica	TSXV	RECO	5	July 21, 2021	View Reports
Samhallsbyggnadsbolaget	STO	SBBB	7	March 23, 2022	View Reports
S&T	XTRA	SANT	1	December 16, 2021	View Reports
Sorrento Therapeutics	NASDAQ	SRNE	1	May 20, 2020	View Reports
Steinhoff	ETR	SNH	1	December 6, 2017	View Reports
Svenska Cellulosa	STO	SCA	6	March 22, 2024	View Reports
Syrah Resources	ASX	SYR	1	December 23, 2016	View Reports
Truecaller	SS	TRUEB	3	October 5, 2022	View Reports
Wirecard	XTRA	WDI	2	November 6, 2020	View Reports
Tyro	ASX	TYR	3	January 19, 2021	View Reports

Important Disclaimer – Please read and acknowledge before continuing

Viceroy Research LLC are an investigative financial research group registered in Delaware, USA.

Our research reports have been prepared for educational purposes only and expresses our opinions. Our reports and any statements made in connection with them are the authors’ opinions, which have been based upon publicly available facts, field research, information, and analysis through our due diligence process, and are not statements of fact. All expressions of opinion are subject to change without notice, and we do not undertake to update or supplement any reports or any of the information, analysis and opinion contained in them. We believe that the publication of our opinions about public companies that we research is in the public interest. We are entitled to our opinions and to the right to express such opinions in a public forum. You can access any information or evidence cited in this report or that we relied on to write this report from information in the public domain.

To the best of our ability and belief, all information contained herein is accurate and reliable, and has been obtained from public sources we believe to be accurate and reliable, and who are not insiders or connected persons of the stocks covered herein or who may otherwise owe any fiduciary duty or duty of confidentiality to the issuer. We have a good-faith belief in everything we write; however, all such information is presented “as is,” without warranty of any kind – whether express or implied.

In no event will we be liable for any direct or indirect trading losses caused by any information available on this report. Think critically about our opinions and do your own research and analysis before making any investment decisions. We are not registered as an investment advisor in any jurisdiction. By downloading, reading or otherwise using our research reports, you agree to do your own research and due diligence before making any investment decision with respect to securities discussed herein, and by doing so, you represent to us that you have sufficient investment sophistication to critically assess the information, analysis and opinions in this report. You should seek the advice of a security professional regarding your stock transactions.

This website, all documents contained herein or any information herein should not be interpreted as an offer, a solicitation of an offer, invitation, marketing of services or products, advertisement, inducement, or representation of any kind, nor as investment advice or a recommendation to buy or sell any investment products or to make any type of investment, or as an opinion on the merits or otherwise of any particular investment or investment strategy.

Any examples or interpretations of investments and investment strategies or trade ideas are intended for illustrative and educational purposes only and are not indicative of the historical or future performance or the chances of success of any particular investment and/or strategy.

You should assume that the authors have a direct or indirect interest/position in all stocks (and/or options, swaps, and other derivative securities related to the stock) and bonds covered herein, and therefore stand to realize monetary gains in the event that the price of either declines.

The authors may continue transacting directly and/or indirectly in the securities of issuers covered herein for an indefinite period and may be long, short, or neutral at any time hereafter regardless of their initial recommendation.